6550 - BENZOYLECGONINE (BZE) immunoassay reagent kits
SOL #: N0018925QZ583Award Notice
Overview
Buyer
Dept Of Defense
Dept Of The Navy
NAVSUP FLT LOG CTR NORFOLK
NORFOLK, VA, 23511-3392, United States
Place of Performance
Place of performance not available
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
PSC
In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)
Set Aside
No set aside specified
Original Source
Timeline
1
Posted
Apr 1, 2026
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of the Navy / NAVSUP FLC Norfolk, Philadelphia Office has awarded MICROGENICS CORPORATION a Firm Fixed-Price contract for Benzoylecgonine (BZE) immunoassay reagent kits valued at $775,453.50.
Scope of Work
The contract provides the Navy and Marine Corps Force Health Protection Command with Benzoylecgonine (BZE) immunoassay reagent kits.
Contract & Timeline
- Type: Firm Fixed-Price (FFP)
- Contract Number: N0018926DB001
- Awardee: MICROGENICS CORPORATION, Fremont, CA
- Value: $775,453.50
- Award Date: March 17, 2026
- Duration: 60-month ordering period
- Set-Aside: Full and Open Competition
- Published: April 1, 2026
Evaluation
Awarded as a result of a full and open competitive solicitation in accordance with FAR 12.
People
Points of Contact
Jorge Candela jorge.e.candelabocanegra.civ@us.navy.milPRIMARY
Files
Files
No files attached to this opportunity
Versions
Version 1Viewing
Award Notice
Posted: Apr 1, 2026